Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Roche's juggernaut Vabysmo rout analyst consensus
In the first quarter, Roche's Vabysmo racked up sales of 847M Swiss francs, which was up 108% and demolished analysts' consensus.
Kevin Dunleavy
Apr 24, 2024 11:29am
Sponsored
3 Principles to Optimize Patient Support Programs
Apr 22, 2024 8:00am
Biogen's fortunes are trending upward thanks to its new launches
Apr 24, 2024 11:24am
Sponsored
MAIC Methodology Matters: Comparing BRUKINSA vs Acalabrutinib in R/R CLL
Apr 1, 2024 8:00am
Chiesi survey shows how Fabry drugs are failing patients
Apr 24, 2024 10:25am
AbbVie starts open casting call for next faces of Botox ads
Apr 24, 2024 8:40am
Marketing News
AstraZeneca and Merck's Lynparza set to 'dominate' PARP market
Apr 24, 2024 8:23am
Day One pressures Novartis with FDA nod for novel RAF inhibitor
Apr 23, 2024 10:13pm
The Bloc taps Ogilvy, McCann alum as associate creative director
Apr 23, 2024 11:25am
Life sci consulting firm Santander makes its debut
Apr 23, 2024 10:40am
See More Marketing News